RXO (NYSE:RXO) PT Raised to $19.50 at TD Cowen

RXO (NYSE:RXO – Get Free Report) had its target price lifted by analysts at TD Cowen from $16.50 to $19.50 in a research report issued to clients and investors on Friday, Briefing.com reports. The firm currently has a “market perform” rating on the stock. TD Cowen’s target price points to a potential downside of 3.85% […]

Leave a Reply

Your email address will not be published.

Previous post Moleculin Biotech (NASDAQ:MBRX) Now Covered by StockNews.com
Next post Fomento Económico Mexicano (NYSE:FMX) Stock Rating Upgraded by HSBC